Yusop, Aga A.

HRN: 01-58-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2022
CEFUROXIME 1.5GM (VIAL)
06/06/2022
06/12/2022
IV
1.5g
Q8h
Abnormal Uterine Bleeding; T/C UTI
Waiting Final Action 
06/06/2022
CLARITHROMYCIN 500MG (CAP)
06/06/2022
06/13/2022
PO
500mg
BID
Cap Mr; Covid Suspect
Waiting Final Action 
06/10/2022
CEFUROXIME 500MG (TAB)
06/10/2022
06/17/2022
PO
500mg
BID
CAP
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: